Skip to content

Capecitabine EP Impurity G

Capecitabine EP Impurity G

Product Description
CAT No.
ALN-C003008
CAS No.
162204-20-8
Mol. F.
C19H26FN3O8
Mol. Wt.
443.4
Stock
Please Inquire
RFQ
Chemical Name : Pentyl [1-(2,3-di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate (as per EP) ; 2′,3′-Di-O-acetyl-5′-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine (as per USP)
Smiles : C[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(F)=C2)NC(OCCCCC)=O)=O)O1)OC(C)=O)OC(C)=O
Inchi : InChI=1S/C16H20FN3O7/c1-3-4-5-6-24-15(22)19-12-9(17)7-20(14(21)18-12)13-11-10(8(2)25-13)26-16(23)27-11/h7-8,10-11,13H,3-6H2,1-2H3,(H,18,19,21,22)/t8-,10-,11-,13-/m1/s1

Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry

By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, ShaileshnFrom American Journal of PharmTech Research (2020), 10(6), 115-133

Validated stability indicating HPLC method for estimation of capecitabine

By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N. – From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658

RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)

By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K. – From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67

Request For Quotation

Related Products